Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Securitas AB to publish the Interim report January-September 2020 on Tuesday, November 3

Securitas AB will publish the interim report for January-September 2020 on Tuesday, November 3, at approx. 1.00 p.m. (CET).Approx. 1.00 p.m. (CET) Report releaseThe report will be sent as a press release from Cision (www.cision.se) and will automatically be published on www.securitas.com when released. 2.00 p.m. (CET) Presentation slides available For presentation slides, follow the link www.securitas.com/presentations   2.30 p.m. (CET) Telephone conference and audio cast Analysts and media are invited to participate in a telephone conference at 2.30 p.m. (CET) where Securitas

Saab strengthens ties to Quebec and Canada through CRIAQ partnership

Saab and the Consortium for Research and Innovation in Aerospace in Quebec (CRIAQ) have signed a Memorandum of Understanding (MoU).This collaborative relationship aims to leverage Quebec's R&D ecosystem’s strengths to encourage the development of collaborative research projects between Saab and Canadian industry, as well as universities and research organizations. This collaboration has been formed to support Saab’s future Industrial and Technological Benefit (ITB) commitments, if the Gripen fighter is selected for Canada’s Future Fighter Capability Project (FFCP). “The quality and

FluoGuide A/S presents at BioStock Live

Copenhagen, Denmark, 14 October 2020 - FluoGuide A/S (“FluoGuide” or “the Company”) presents at BioStock Live on Thursday 15 October 2020 at 12.00 CEST.Together with four other Life Science companies, FluoGuide will present at BioStock Live from their studio at Medicon Village in Lund to talk about the Company’s ongoing clinical trial of its lead product FG001, which will commence with a site inspection by the Danish Medicine Agency. The detailes about the clinical trial is presented in the interim report from Q2-2020 (page 6) released on 14 August 2020. The event starts at 10:00 CEST

Ratos Nomination Committee and 2021 AGM

Ratos's Annual General Meeting (AGM) will be held on 5 May 2021 at Skandiascenen, Cirkus, in Stockholm, Sweden.In accordance with the policy for appointing Ratos’s Nomination Committee, it is hereby announced that the company’s major owners/owner constellations have appointed a Nomination Committee with the Chairman of the Board Per-Olof Söderberg as the convener. The Nomination Committee comprises the following individuals: · Jenny Parnesten, nominated by the Ragnar Söderberg Foundation, and own and related parties' holdings · Jan Söderberg, own holdings · Maria Söderberg,

Last day for subscription in the ongoing rights issue is October 19, 2020

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, WITHIN OR TO THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND OR IN ANY OTHER JURISDICTION WHERE SUCH RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES. Hørsholm, Denmark, October 14, 2020 – In accordance with previous communication, Monday, October 19, 2020 is the last day for subscription in ExpreS2ion Biotech Holding AB (publ) (“ExpreS2ion” or the “Company”) share issue with

Tokmanni Group Corporation will publish its third quarter 2020 business review on 29 October 2020

Tokmanni Group Corporation        Investor news        14 October 2020 at 2:30 pmTokmanni will publish its third quarter 2020 business review on 29 October 2020 at approximately 8:30 am (Finnish time). The stock exchange release and the presentation materials in Finnish and in English will be available on the company's website at https://ir.tokmanni.fi/en/investors as soon as possible after the publication of the report. Tokmanni’s CEO Mika Rautiainen and CFO Markku Pirskanen will present the review to analysts, investors and media representatives on the publication day at 10:00 am at

Eco Wave Power selected to join 14 leading edge companies focused on solving the world’s greatest challenges at Unreasonable Impact 2020

Barclays and Unreasonable Group  continue commitment to scaling up entrepreneurial solutions helping employ thousands globally while solving some of the world’s most pressing environmental and societal challenges.14/10/2020 – Stockholm, Sweden –  Eco Wave Power (Stock Symbol: ECOWVE) has been selected to join 14 other ground breaking growth stage ventures at the 2020 Unreasonable Impact UK & Europe programme . With the global pandemic continuing to have an enormous impact on all

Invitation to Telia Company’s interim report January-September 2020

Telia Company’s interim report January-September will be announced on Wednesday October 21, at around 7.00 CET.At 10.00 CET, Allison Kirkby, President and Chief Executive Officer, and Per Christian Mørland, Chief Financial Officer, will present the Interim Report via a telephone conference. Presentation materials referred to during the conference will be available at www.teliacompany.com.    Telephone conference in connection with the press and analyst conferenceYou can listen to the conference live over the phone and attend the Q&A session after the presentation.To ensure that

QUARTERLY REPORT, THIRD QUARTER 2020

Press release: Stockholm, 14 October 2020 13.00 CETHIGHLIGHTS OF THE THIRD QUARTER 2020 · Net sales was 130 MSEK (82) · EBITDA was 58 MSEK (33) · EBIT was 40 MSEK (3) · Earnings per share was 0.19 SEK (0.01) non-diluted, 0.18 SEK (0.01) diluted · Cash and cash equivalents were 30 MSEK (7) · Investments were 4 MSEK (28) · The production was about 433 000 (358 000) ounces silver, 923 (1 081) ounces gold, 419 (445) tonnes lead, and 818 (1 010) tonnes zinc in concentrates · Due to the pricing mechanism in use, the final metal sales prices of Q2 2020 increased

Notice of extraordinary general meeting in AB Sagax (publ)

The shareholders of AB Sagax (publ), 556520-0028, (”the Company”) are hereby invited to the Extraordinary General Meeting (EGM) to be held on Tuesday 10 November 2020.Due to the continued spread of the coronavirus and the authorities’ regulations/advice on avoiding public gatherings, the Board of Directors has resolved that the EGM will be held without physical presence of shareholders, proxies or external parties and that shareholders only can exercise their voting rights by voting in advance in accordance with the procedure prescribed below. Information on the resolutions passed at the

NextCell presents at “Investerarjakten”

NextCell Pharma AB (“NextCell”) will today at 15:00 present at Investerarjakten. Viewers have the possibility to ask questions directly to CEO Mathias Svahn. The event is broadcast live on Studio Direct's youtube channel, the facebook group Aktier and on Investerarbrevet.se between 13:00-17:00.In September, NextCell published positive data for its Phase II study, ProTrans-2. The patients with type 1 diabetes treated with a dose of the stem cell drug ProTrans had maintained a statistically significantly higher insulin production after 12 months compared with the patients treated with placebo

The Swedish defense and security company Saab orders XMReality Remote Guidance to support their global operations

XMReality AB (publ) has signed a three-year contract with Saab AB, a Swedish defense and security company who serves the global market with services and solutions within military defense and civil security, for Remote Guidance[TM]. The initial order value is approximately 1 600 TSEK.The initial order covers the upcoming 9 months, after this period the number of licenses will be reviewed. The contract and order cover software licenses and server maintenance without any hardware content. As a strong player within defense and security, Saab has very high standards for their operations which

Launch of ORGANOWOOD® wood protection in the USA with Woodborn USA as distribution partner

OrganoClick's subsidiary OrganoWood markets and supply modified wood and wood treatment products. As its next step of expansion, ORGANOWOOD® wood protection system is now launched on the US market through a distribution agreement with the wood paint and coating distributor Woodborn USA. Through their sales team, ORGANOWOOD® wood protection will now be sold and distributed to paint dealers and building supply chains across the US market.OrganoWoods wood protection products were the first in Sweden to be awarded with the Swedish Society for Nature Conservation eco-label "Good Environmental

New insight into neovessel formation shows promise in future treatment of cardiovascular diseases

A new study by researchers at the University of Eastern Finland provides novel insight into the previously unknown effects of factors regulating blood vessel formation. In the study, bone morphogenetic factor 6, i.e. BMP6, was shown – for the first time - to regulate blood vessel formation via vascular endothelial growth factor receptor 2 (VEGFR2) and Hippo signalling pathway. The findings can be used in developing treatments for cardiovascular diseases.  Cardiovascular diseases are the leading cause of death in the Western world. In many of these diseases, blood circulation is decreased

iLOQ and Locare reach an agreement to install digital locks in their developments

iLOQ has signed an agreement with one of the largest real estate investment managers in Spain – Locare.iLOQ is constantly growing and expanding its market. The philosophy of working, growing and improving is a clear example of the expansion of the company in Spain where digital locking solutions are clearly disrupting the market. Recently, iLOQ signed an agreement with one of the largest real estate investment managers in Spain – Locare – who has chosen to install battery-free electronic locking systems in its developments and residential buildings. Locare is a platform for capital

Attendo's report for the third quarter 2020 to be published on 23 October - Invitation to teleconference

On 23 October, around 08:00 am (CET), Attendo will present its third quarter results for 2020. Investors, analysts and journalists are hereby invited to participate in a teleconference at 10:00 am (CET) on the same date.The teleconference will be hosted by Attendo’s CEO Martin Tivéus and CFO Fredrik Lagercrantz. The presentation will be held in English. Date:             23 October 2020Time:             10:00 am (CET) To participate in the conference, please dial in on any number below at least ten minutes before the start of the call: SE:                +46 8 50 55 83 53FI:

Eco Wave Power selected to join 14 leading edge companies focused on solving the world’s greatest challenges at Unreasonable Impact 2020

Barclays and Unreasonable Group  continue commitment to scaling up entrepreneurial solutions helping employ thousands globally while solving some of the world’s most pressing environmental and societal challenges.14/10/2020 – Stockholm, Sweden –  Eco Wave Power (Stock Symbol: ECOWVE) has been selected to join 14 other ground breaking growth stage ventures at the 2020 Unreasonable Impact UK & Europe programme . With the global pandemic continuing to have an enormous impact on all

Nel ASA: Receives first H2Station™ order in Poland

(Oslo, 14 October 2020) Nel Hydrogen Fueling, a subsidiary of Nel ASA (Nel, OSE:NEL) has received a purchase order from ZE PAK SA (ZE PAK) for H2Station™ hydrogen fueling stations which will be used to fuel passenger vehicles and buses in Poland. "We’re excited to enter yet another country in Europe with our H2Station™ fueling solutions. We see attractive market opportunities in Poland, and are proud that ZE PAK, which is the leading energy company in Poland has chosen our fueling solutions," says Jens Egholt, Senior Director Global Sales of Nel Hydrogen Fueling. The value of the

Recipharm’s proprietary molecule Erdosteine has been positively tested as part of COVID-19 treatment

Recipharm is pleased to announce that the results of the study with Erdosteine as an add-on treatment for COVID-19 patients are now available. The clinical study involved 20 patients affected by COVID-19 with severe respiratory failure, hospitalized in one of the major COVID-19 centres of Milan, in Lombardy, the Italian region mostly affected by SARS-CoV-2. The study indicates that patients taking Erdosteine after hospital discharge benefit significant improvements in health-related quality of life parameters (HRQoL) and dyspnoea. This study is one of the first to report HRQoL details

NPRO: Invitation to presentation of third quarter 2020

Norwegian Property ASA (OSE: NPRO, NPRO.OL) releases its third quarter results for 2020 on Wednesday 21 October 2020, and we are pleased to invite investors, analysts and media to a presentation of the results. The presentation will be held in Norwegian only, and it will be held by Bent Oustad (CEO) and Haavard Rønning (CFO). According to the infection control rules we urge all participants to maintain a social distance of 1 meter, and we suggest following the presentation live via webcast. Date: Wednesday 21 October 2020Time: 08:30 a.m. Central European TimeLocation: Restaurant

Instalco wins contract on the construction of cycling velodrome in Norway

Instalco’s Norwegian subsidiary, Vito Teknisk Entreprenör AS, has been engaged for the heating and plumbing work associated with construction of a new velodrome and cycling centre in Asker, near Oslo. The client is Veidekke Entreprenør and the order value for Vito is approximately SEK 41 million.Instalco’s Norwegian subsidiary, Vito Teknisk Entreprenör AS, has been engaged for the heating and plumbing work associated with construction of a new velodrome and cycling centre in Asker, near Oslo. The client is Veidekke Entreprenør and the order value for Vito is approximately SEK 41 million.

Climeon’s nomination committee for the Annual General Meeting 2021

The nomination committee of Climeon AB (publ) for the Annual General Meeting 2021 (AGM) is hereby announced. It consists of the following representatives appointed by the four largest shareholders as per 31 August 2020, as well as the Chairman of the Board: · Helen Öström, appointed by the shareholder Thomas Öström (51.7% of the votes and 18.3% of the shares as per 31 August 2020) · Anne Holm Rannaleet, appointed by the shareholder Joachim Karthäuser (27.2% of the votes and 9.5% of the shares as per 31 August 2020) · Niklas Johansson, appointed by the shareholder Handelsbanken

BioStock: Cereno Scientific – a rare opportunity in cardiovascular diseases

Cardiovascular diseases (CVD) are the most common cause of death in the world. An estimated 17,9 million people are expected to die every year, a figure that is forecasted to rise to 22,2 million by 2030. Gothenburg-based biotech company Cereno Scientific is developing new a new class of therapies in CVD, using an epigenetic modulation platform. Earlier this year, the FDA granted Cereno Scientific orphan drug designation-status (ODD) for its leading clinical phase II candidate CS1 in pulmonary arterial hypertension (PAH). BioStock has now published a company update on Cereno Scientific.Read

Nixu to start to acquire the company’s own shares

Nixu Corporation Stock Exchange Release on October 14, 2020 at 11:20 am EESTThe Board of Directors of Nixu Corporation has decided to commence acquiring the company’s own shares on the basis of the authorization given by the Annual General Meeting held on April 7, 2020. The maximum number of shares to be acquired is 10,000 corresponding to 0.13% of the total number of shares. Nixu currently holds a total of 12,405 own shares. The share buyback shall start on October 15, 2020 at the earliest, and end by December 31, 2020, at the latest. The shares shall be acquired through public trading

There are no items matching the current filter
There are no more items matching the current filter
Back to top